Imiquad Cream: Targeted Immune Response for Skin Lesions - Evidence-Based Review

Product Description Imiquad Cream is a topical immunomodulatory preparation for dermatological use. Its active ingredient, imiquimod, is a Toll-like receptor 7 (TLR7) agonist. It is not a direct antiviral or cytotoxic agent. Instead, it works by locally stimulating the body’s own innate and adaptive immune responses, leading to the targeted destruction of virally infected or dysplastic cells. It is presented as a 5% cream in single-use sachets or multi-use packets, with the standard regimen involving application 3 times per week, typically on Monday, Wednesday, and Friday evenings, for a prescribed duration of up to 16 weeks, depending on the indication and response.